Total Payments
$633,974
2024 Payments
$75,607
Companies
47
Transactions
921
Medicare Patients
3,102
Medicare Billing
$391,243
Payment Breakdown by Category
Consulting$299,754 (47.3%)
Other$238,621 (37.6%)
Travel$60,722 (9.6%)
Food & Beverage$23,309 (3.7%)
Research$11,478 (1.8%)
Education$90.24 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $299,754 | 93 | 47.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $227,597 | 116 | 35.9% |
| Travel and Lodging | $60,722 | 147 | 9.6% |
| Food and Beverage | $23,309 | 538 | 3.7% |
| Unspecified | $11,478 | 17 | 1.8% |
| Honoraria | $11,024 | 6 | 1.7% |
| Education | $90.24 | 4 | 0.0% |
Payments by Type
General
$622,497
904 transactions
Research
$11,478
17 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $236,218 | 269 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $121,061 | 118 | $0 (2024) |
| MERZ NORTH AMERICA, INC. | $55,418 | 24 | $0 (2024) |
| GENZYME CORPORATION | $37,875 | 59 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $36,798 | 12 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $30,773 | 52 | $0 (2021) |
| Regeneron Pharmaceuticals, Inc. | $16,433 | 14 | $0 (2024) |
| Merck Sharp & Dohme LLC | $15,213 | 14 | $0 (2023) |
| Optinose US, Inc. | $14,682 | 38 | $0 (2024) |
| Blueprint Medicines Corporation | $7,592 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $75,607 | 184 | AstraZeneca Pharmaceuticals LP ($44,525) |
| 2023 | $107,522 | 186 | AstraZeneca Pharmaceuticals LP ($53,257) |
| 2022 | $54,527 | 116 | AstraZeneca Pharmaceuticals LP ($35,967) |
| 2021 | $54,637 | 44 | AstraZeneca Pharmaceuticals LP ($30,486) |
| 2020 | $24,640 | 30 | MERZ NORTH AMERICA, INC. ($8,382) |
| 2019 | $128,349 | 113 | Regeneron Healthcare Solutions, Inc. ($43,694) |
| 2018 | $126,699 | 147 | Regeneron Healthcare Solutions, Inc. ($39,246) |
| 2017 | $61,994 | 101 | Regeneron Healthcare Solutions, Inc. ($19,788) |
All Payment Transactions
921 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Hikma Pharmaceuticals USA | Ryaltris (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 12/20/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $26.14 | General |
| Category: Inflammation | ||||||
| 12/19/2024 | BioCryst US Sales Co., LLC | ORLADEYO (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $21.92 | General |
| 12/11/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $537.00 | General |
| 12/10/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: DERMATOLOGY | ||||||
| 12/09/2024 | Pharming Healthcare, Inc. | RUCONEST (Biological) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: BIOLOGIC | ||||||
| 12/06/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: DERMATOLOGY | ||||||
| 12/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.10 | General |
| Category: Immunology | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,300.00 | General |
| Category: Respiratory | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,600.00 | General |
| Category: Respiratory | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: IMMUNOLOGY | ||||||
| 12/01/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | — | In-kind items and services | $233.64 | Research |
| Study: DUPIXENT CLINICAL DEVELOPMENT PROGRAM • Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/27/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,050.00 | General |
| Category: Respiratory | ||||||
| 11/25/2024 | MERZ NORTH AMERICA, INC. | Xeomin (Biological) | Consulting Fee | Cash or cash equivalent | $6,000.00 | General |
| Category: Dermatology | ||||||
| 11/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $8.18 | General |
| Category: Immunology | ||||||
| 11/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Travel and Lodging | In-kind items and services | $581.95 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Travel and Lodging | In-kind items and services | $245.35 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Travel and Lodging | In-kind items and services | $240.15 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $106.55 | General |
| Category: Respiratory | ||||||
| 11/15/2024 | Hikma Pharmaceuticals USA | Ryaltris (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 11/15/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: DERMATOLOGY | ||||||
| 11/14/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $38.84 | General |
| Category: Oncology / Rare Diseases | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Randomized, Double Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in Patients With Persistent Asthma | SANOFI-AVENTIS U.S. LLC | $5,150 | 9 |
| A RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER CLINICAL STUDY TO ASSESS THE EFFICACY AND SAFETY OF TWICE DAILY ADMINISTRATION OF FLUTICASONE PROPIONATE 100 MCG AND SALMETEROL XINAFOATE 50 MCG DRY POWDER INHALER COMPARED TO ADMINISTRATION WITH ADVAIR DISKUS 10050 MCG TWICE DAILY AND PLACEBO IN PATIENTS 12 YEARS OF AGE AND OLDER WITH REVERSIBLE PERSISTENT ASTHMA INCLUDING A 3-WEEK OPEN-LABEL EXTENSION TO ASSESS INHALER ROBUSTNESS | Lupin Inc. | $3,150 | 2 |
| GSP301-304 | Glenmark Pharmaceuticals Inc. | $2,547 | 4 |
| A randomized, double blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of duplilumab in patients with persistent asthma | SANOFI-AVENTIS U.S. LLC | $397.50 | 1 |
| DUPIXENT CLINICAL DEVELOPMENT PROGRAM | Regeneron Pharmaceuticals, Inc. | $233.64 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 570 | 4,609 | $146,292 | $80,743 |
| 2022 | 17 | 929 | 6,654 | $218,187 | $126,123 |
| 2021 | 14 | 806 | 5,869 | $181,396 | $103,683 |
| 2020 | 16 | 797 | 4,864 | $155,853 | $80,694 |
Total Patients
3,102
Total Services
21,996
Medicare Billing
$391,243
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 137 | 222 | $31,968 | $21,815 | 68.2% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 26 | 348 | $17,400 | $11,807 | 67.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 67 | 67 | $16,616 | $9,060 | 54.5% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 52 | 2,395 | $20,358 | $8,178 | 40.2% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 28 | 193 | $11,580 | $8,060 | 69.6% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 30 | 536 | $12,698 | $7,103 | 55.9% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 15 | 96 | $7,680 | $4,415 | 57.5% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 36 | 422 | $10,972 | $4,177 | 38.1% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 66 | 95 | $8,075 | $2,164 | 26.8% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2023 | 41 | 49 | $1,715 | $822.50 | 48.0% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 22 | 22 | $2,970 | $773.08 | 26.0% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2023 | 11 | 102 | $1,020 | $672.77 | 66.0% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 12 | 12 | $1,020 | $627.00 | 61.5% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 12 | 12 | $1,080 | $596.04 | 55.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 15 | 38 | $1,140 | $473.86 | 41.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 251 | 462 | $66,528 | $47,337 | 71.2% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 76 | 3,423 | $29,096 | $12,304 | 42.3% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 37 | 1,026 | $16,416 | $11,941 | 72.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 81 | 81 | $20,088 | $10,253 | 51.0% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 50 | 197 | $11,820 | $8,635 | 73.1% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2022 | 35 | 219 | $10,950 | $7,715 | 70.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 47 | 91 | $11,739 | $6,307 | 53.7% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 37 | 515 | $13,390 | $5,322 | 39.7% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 22 | 93 | $7,440 | $4,779 | 64.2% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 127 | 185 | $15,725 | $4,131 | 26.3% |
About Dr. Warner Carr, MD
Dr. Warner Carr, MD is a Internal Medicine healthcare provider based in Laguna Niguel, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1184798001.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Warner Carr, MD has received a total of $633,974 in payments from pharmaceutical and medical device companies, with $75,607 received in 2024. These payments were reported across 921 transactions from 47 companies. The most common payment nature is "Consulting Fee" ($299,754).
As a Medicare-enrolled provider, Carr has provided services to 3,102 Medicare beneficiaries, totaling 21,996 services with total Medicare billing of $391,243. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Allergy, Allergy
- Location Laguna Niguel, CA
- Active Since 11/20/2006
- Last Updated 07/11/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1184798001
Products in Payments
- DUPIXENT DUPILUMAB INJECTION (Biological) $75,234
- DUPIXENT (Biological) $69,188
- TEZSPIRE (Biological) $63,910
- FASENRA (Drug) $59,605
- Xeomin (Biological) $47,488
- AIRSUPRA (Drug) $42,871
- SOLIQUA 100/33 (Drug) $31,150
- DUPIXENT (Drug) $26,936
- FASENRA (Biological) $21,505
- XEOMIN (Biological) $14,830
- Xhance (Drug) $14,682
- PROAIR (Drug) $7,322
- PALFORZIA (Biological) $7,188
- CINQAIR (Drug) $7,057
- Ryaltris (Drug) $6,890
- ATOPIC DERMATITIS - DISEASE (Drug) $6,603
- CINQAIR (Biological) $6,537
- Dymista (Drug) $6,156
- ProAir Digihaler (Drug) $4,585
- Odactra (Drug) $4,568
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Laguna Niguel
Dr. Amitpal Kohli, M.d, M.D
Internal Medicine — Payments: $9,181
Internal Medicine $9,181
Dr. Stuart Seigel, Md, MD
Internal Medicine — Payments: $7,382
Internal Medicine $7,382
Dr. Christine Lee-Kim, D.o, D.O
Internal Medicine — Payments: $6,487
Internal Medicine $6,487
Bassam Bilal, M.d, M.D
Internal Medicine — Payments: $4,209
Internal Medicine $4,209
Dr. Zahra Shahim, Md, MD
Internal Medicine — Payments: $3,656
Internal Medicine $3,656
Dr. Susan Dindot, Md, MD
Internal Medicine — Payments: $2,425
Internal Medicine $2,425